Mode
Text Size
Log in / Sign up

Varicella

Part of Herpesviridae Infections

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Varicella

31 trials tracked for Varicella: 23 in phase 3 or 4 and 10 with published results. The most-cited published study has 94 citations.

31Trials tracked
23Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 3 23 Phase 2 5 Other / NA 3
  1. Phase 3 Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox Completed · 94 cited
  2. Phase 3 Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) Completed · 30 cited
  3. Phase 3 Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM Completed · 19 cited
  4. Phase 3 Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV Completed · 19 cited
  5. Phase 3 Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) Completed · 13 cited
  6. Phase 3 Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children Completed · 10 cited
Show 25 more trials
  1. Phase 3 ProQuad® Intramuscular vs Subcutaneous Completed · 10 cited
  2. Phase 3 Safety Study of ProQuad® rHA in Infants (V221-037) Completed · 9 cited
  3. Phase 3 Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058) Completed · 3 cited
  4. Phase 3 Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03) Completed · 2 cited
  5. Phase 3 Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Completed
  6. Phase 3 Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients Completed
  7. Phase 3 Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed) Completed
  8. Phase 3 Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Completed
  9. Phase 3 Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines Completed
  10. Phase 3 V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) Completed
  11. Phase 3 ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) Completed
  12. Phase 3 Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063) Completed
  13. Phase 3 Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers Completed
  14. Phase 3 A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Completed
  15. Phase 3 A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) Completed
  16. Phase 3 Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) Completed
  17. Phase 3 Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) Completed
  18. Phase 2 ProQuad Dose Selection Study (V221-011)(COMPLETED) Completed
  19. Phase 2 Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age Completed
  20. Phase 2 Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds Completed
  21. Phase 2 Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). Completed
  22. Phase 2 Study of Two Formulations of GSK Biologicals' Varicella Vaccine Completed
  23. N/A Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox) Completed
  24. N/A Re-examination Study For Varivax (V210-059 AM2) Completed
  25. N/A A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED) Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Herpesviridae Infections

Related studies from across the Herpesviridae Infections family.

Questions about Varicella

Does the field report describe new Varicella testing in Minnesota?

Yes, a field report confirms that the Minnesota Department of Health has expanded laboratory testing for varicella.

Full answer →
How well did the random forest model perform for Varicella?

A random forest model predicted pediatric varicella encephalitis with an area under the curve of 0.950, showing excellent performance in a study of 201 children.

Full answer →